Showing 1181-1190 of 23044 results for "".
Management Approaches in Radiographically Isolated Syndrome
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/management-approaches-in-radiographically-isolated-syndrome/32089/How best to define radiographically isolated syndrome has been the subject of debate; challenges in determining the best management approach remain.The Heritage of Platelet-Derived Growth Factor
https://modernaesthetics.com/topics/regenerative-medicine/the-heritage-of-pdgf/48868/From its discovery nearly half a century ago to its current place in patient care and scientific conversation in aesthetic medicine, poorly healing skin wounds, orthopedics, and dental surgical reconstruction, platelet-derived growth factor (PDGF) stands as both a milestone of molecular biology andAdjuvanted vs High-Dose Influenza Vaccines: A Real-World Evidence Study
https://reachmd.com/programs/medical-industry-feature/adjuvanted-vs-high-dose-influenza-vaccines-a-real-world-evidence-study/26668/Explore data comparing adjuvanted and high-dose influenza vaccines for adults 65 and older.Collaborative Care for CRSwNP Expert and Patient Insights
https://reachmd.com/programs/cme/collaborative-care-for-crswnp-expert-and-patient-insights/36695/Chronic rhinosinusitis with nasal polyps (CRSwNP) presents a large burden on more than 3 million patients with the conditions — especially when intertwined with asthma and allergy. Join our discussion between patients with CRSwNP and leading experts in ENT, allergy, and pulmonary medicine as they:Expert Consensus on Physical Therapy for Acute and Sub-Acute Low Back Pain
https://reachmd.com/programs/clinicians-roundtable/expert-consensus-on-physical-therapy-for-acute-and-sub-acute-low-back-pain/26729/What are some effective interventions for managing low back pain? That’s the exact question an expert consensus sought to answer; here are the results.Coming & Going: April 2022
https://modernaesthetics.com/ma-issues-index/2022-mar-apr/coming-going-april-2022/35157/Bridging the Gap in AYA Cure Rates
https://reachmd.com/programs/medical-industry-feature/bridging-the-gap-in-aya-cure-rates/35630/Explore the latest data on asparaginase-based therapies for adolescents and young adults with acute lymphoblastic leukemia and lymphoblastic lymphoma. For US HCPs Only.Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
https://reachmd.com/programs/medical-industry-feature/amyloid-tau-alzheimers-disease-progression/37874/The prevalence of dementia is projected to almost double every 20 years.1 Alzheimer’s disease (AD) is the most common cause of dementia,2 making early diagnosis and management increasingly important. Based on our current understanding of its pathology, AD is an amyloid driven tauopathy3 with biomarkRethinking Schizophrenia Treatment Through Muscarinic Modulation
https://reachmd.com/programs/cme/rethinking-schizophrenia-treatment-through-muscarinic-modulation/37103/Learn expert insights on muscarinic antipsychotics in schizophrenia, including mechanisms, safety, and switching considerations.Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
https://reachmd.com/programs/cme/direct-from-the-heart-failure-clinic-novel-device-therapy-for-patients-with-hfref/14473/Learn about baroreflex activation therapy (BAT), an implantable, FDA-approved cardiac device that’s improving exercise capacity, QoL & more.